Today: 20 May 2026
Browse Category

NASDAQ:SNPS 19 December 2025 - 17 May 2026

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
17 May 2026
··
Synopsys Stock Turns Back Toward AI Chip Race After New TSMC Design Push

Synopsys Stock Turns Back Toward AI Chip Race After New TSMC Design Push

Synopsys announced expanded collaboration with TSMC on advanced chipmaking and packaging for AI, unveiling new design and analysis tools for TSMC’s 3nm, 2nm, A16, and A14 nodes. Shares of Synopsys rose to $483.00 early Friday after an eight-day winning streak ended Thursday. Cadence and Siemens also updated TSMC-related design tools. The news coincided with TSMC’s North America Technology Symposium in Santa Clara.
24 April 2026
···
Synopsys Stock Price Slides 5% Friday as Tech Rout Erases Elliott Boost

Synopsys Stock Price Slides 5% Friday as Tech Rout Erases Elliott Boost

Synopsys shares fell 5.4% to $380.47 on Friday, underperforming Cadence as tech stocks slid in a broad Wall Street selloff. The drop erased gains from Elliott Investment Management’s recent stake, leaving Synopsys about 12% below Monday’s close. The Nasdaq lost 2.15% and the S&P 500 software index hit a five-month low. Investors cited rising oil prices and yields as ongoing risks for high-valuation software stocks.
28 March 2026
··
Synopsys stock (SNPS) set for Monday test after Morgan Stanley downgrade, Converge event in focus

Synopsys stock (SNPS) set for Monday test after Morgan Stanley downgrade, Converge event in focus

Morgan Stanley downgraded Synopsys to Equal-Weight and cut its price target to $480, sending shares down 2.8% to $414 on Friday. The stock has fallen about 8% over two sessions and now trades 36% below its July high. Synopsys reported Q1 revenue of $2.409 billion, with Ansys contributing $886 million. The company will address investors at its March 11 Converge event.
1 March 2026
·
Synopsys (SNPS) stock price at $414: why shares fell and what Wall Street watches next

Synopsys (SNPS) stock price at $414: why shares fell and what Wall Street watches next

Synopsys shares fell 2.8% to $414 Friday, extending a two-day drop to about 8% after its quarterly outlook and renewed concerns over China export restrictions. The company reported quarterly revenue of $2.409 billion and non-GAAP EPS of $3.77, with its Design IP unit revenue down over 6%. Morgan Stanley downgraded the stock, citing slower core EDA growth and rising competition. Synopsys’ next Form 10-Q is due by March 12.
28 February 2026
··
Synopsys stock slips again after Tuesday’s rout as AI disruption fears hit software

Synopsys stock slips again after Tuesday’s rout as AI disruption fears hit software

Synopsys shares fell 1.2% to $414.07 Wednesday afternoon, extending losses after an 8.5% drop Tuesday during a broad software sector selloff. Trading volume Tuesday more than doubled its 50-day average, with the stock now 36% below its July peak. Traders remain defensive, with options activity skewed toward downside bets. Synopsys reports Q1 earnings after markets close on Feb. 25.
4 February 2026
··
Intuit stock drops 11% after-hours as AI disruption fears spread — what investors watch next

Intuit stock drops 11% after-hours as AI disruption fears spread — what investors watch next

Intuit shares plunged 10.9% to $434.09 in after-hours trading Tuesday, after falling 11% during the session. The S&P 500 software and services index dropped 3.8%, with Salesforce, Datadog, Adobe, Synopsys, and Atlassian also down sharply. The Nasdaq Composite lost 1.4%. Analysts cited aggressive repricing of software stocks as AI offerings from Anthropic raised concerns over future growth and competition.
4 February 2026
·········
Synopsys stock rises after CES automotive push as AI trade returns to tech

Synopsys stock rises after CES automotive push as AI trade returns to tech

Synopsys shares rose 2.2% to $519.70 in after-hours trading Wednesday after unveiling new automotive engineering tools and partnerships at CES 2026. The company highlighted updates to sensor simulation and virtual developer kits, plus work with Samsung and the FIA. A securities class action remains pending in federal court. Synopsys will present next at the Needham Growth Conference on Jan. 15.
8 January 2026
·····
Synopsys stock rises nearly 3% today as Loop Capital lifts target to $600; SNPS outperforms peers

Synopsys stock rises nearly 3% today as Loop Capital lifts target to $600; SNPS outperforms peers

Synopsys shares climbed 2.8% to $482.78 Friday after Loop Capital raised its price target to $600 and reiterated a buy rating. The iShares Semiconductor ETF rose 4.7% and the VanEck Semiconductor ETF gained 4.1%, outpacing broader indexes. Nvidia recently took a $2 billion stake in Synopsys. Synopsys completed its $35 billion acquisition of Ansys in July.
2 January 2026
··
Synopsys stock slips today as SNPS faces lawsuit deadline in thin year-end trade

Synopsys stock slips today as SNPS faces lawsuit deadline in thin year-end trade

Synopsys shares fell 0.6% to $475.91 in late-afternoon New York trading as investors eyed a Tuesday deadline to seek lead-plaintiff status in a securities class action. The stock tracked a muted tech sector, with Cadence down 0.4% and SOXX flat. The lawsuit alleges misleading statements about Synopsys’ Design IP business. Year-end liquidity remained thin ahead of the Fed minutes release.
30 December 2025
·
Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes

Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes

Synopsys shares rose 0.4% to $478.97 Monday, outperforming the Nasdaq as broader markets slipped in thin year-end trading. Investor-law firms reminded shareholders of a Dec. 30 deadline in a securities class-action case tied to alleged misstatements in the company’s Design IP business. About 1.33 million Synopsys shares traded, with the stock moving between $471.28 and $484.33.
30 December 2025
··
Synopsys stock today rises as tech slips, Dec. 30 lawsuit deadline nears

Synopsys stock today rises as tech slips, Dec. 30 lawsuit deadline nears

Synopsys shares rose 0.4% to $479.18 Monday, bucking declines in major tech indexes. Law firms flagged a Dec. 30 deadline for investors to seek lead plaintiff status in a proposed securities class action alleging misleading statements about the company’s Design IP business. Cadence Design, a key rival, slipped 0.2%. Traders monitored Fed minutes and jobless claims in a quiet holiday week.
29 December 2025
·
Synopsys (SNPS) Stock After Hours on Dec. 18, 2025: What Moved Shares After the Bell and What to Watch Before Friday’s Market Open

Synopsys (SNPS) Stock After Hours on Dec. 18, 2025: What Moved Shares After the Bell and What to Watch Before Friday’s Market Open

Synopsys shares closed at $458.13 on Dec. 18, up 1.12%, then slipped fractionally to about $458 in after-hours trading. Trading volume was roughly 1.7 million, below the 50-day average. The company lagged peers like Applied Materials and Lam Research. Multiple law firms announced a securities class action tied to Synopsys, with a lead plaintiff deadline of Dec. 30, 2025.
19 December 2025
·
1 2 3

Stock Market Today

  • Tesla Q1 2026 Earnings Beat; Stock Faces Mixed Outlook for 2030
    May 20, 2026, 10:24 AM EDT. Tesla (TSLA) reported Q1 2026 earnings per share (EPS) of $0.41, exceeding the $0.36 consensus, with automotive gross margin rising to 21.1% from 16.2%. Operating income increased 135.8% year-on-year (YoY), and services plus Full Self-Driving (FSD) revenue jumped 42% to $3.75 billion, with 1.28 million active FSD subscriptions up 51%. Despite strong fundamentals, Tesla shares fell 8.83% year-to-date to $409.99 amid skepticism about AI monetization and scaling autonomy. Wall Street's average target is about $412, while a proprietary model estimates a base case price of $510 by 2030, with a bull case of $645. Achieving $650 requires significant price-to-earnings multiple expansion or sharp EPS growth from AI ventures, amid challenges like increased operating expenses and production constraints.

Latest articles

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

20 May 2026
POET Technologies shares rose 11% to $14.55 in early Nasdaq trading Wednesday after closing a US$400 million direct offering of 19 million shares and warrants. The rebound followed an 8% drop Tuesday on dilution concerns. The company reported Q1 revenue of $503,389 and a net loss of $12.3 million. A recent $50 million order from Lumilens could scale to $500 million over five years if production ramps up.
Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

20 May 2026
Nokia shares rose 3.37% in Helsinki trading Wednesday after the FCC conditionally approved its Beacons and ONT devices, exempting them from U.S. Covered List restrictions. Nokia also transferred 975,289 treasury shares to equity plan participants. Dell’Oro Group forecasts the optical transport equipment market will grow 16% in 2026, driven by AI data centers.
Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

20 May 2026
Biogen completed its acquisition of Apellis Pharmaceuticals, removing APLS shares from Nasdaq and paying investors $41 per share plus a contingent value right tied to Syfovre sales. Apellis shareholders tendered 82.4% of outstanding stock before the offer expired May 13. Biogen shares rose 0.9% to $192.34 Wednesday. The CVR could pay up to $4 if Syfovre meets future sales targets.
Go toTop